Baseline characteristics of patients with acute ischaemic stroke included in the randomised controlled Find-AF 2 trial.

ABSTRACT:

Background

In the Find-AF 2 randomised controlled trial, we investigate whether a risk-adapted intensified heart rhythm monitoring with subsequent initiation of oral anticoagulation in ischaemic stroke patients leads to a reduction of recurrent ischaemic stroke and systemic embolism. The objective of this analysis is to present baseline characteristics of the overall Find-AF 2 study population and stratified by low or high risk for developing AF.

Methods

The Find-AF 2 trial included acute ischaemic stroke patients ≥ 60 years of age within 30 days of ischaemic stroke of any cause. Before randomisation, patients received a 24-h Holter-ECG to exclude those with easily detectable AF and to determine the presence or absence of enhanced supraventricular ectopic activity (ESVEA), u

SUBMITTER: Wasser K 

PROVIDER: S-EPMC12203715 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature